SCHEMBL6768026

SCHEMBL6768026

N=C(NO)c1ccc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2c1.O=C1CCN(Cc2nc(-c3ccc4ncnc(Nc5ccc6c(cnn6Cc6ccccc6)c5)c4c3)no2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 18/20 0.48
EGFR P00533 16/20 0.48
ERBB4 Q15303 12/20 0.47
JAK3 P52333 8/20 0.47
MEN1 O00255 1/20 0.46
RGS12 O14924 1/20 0.46
GMNN O75496 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
RAF1 P04049 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
MAPT P10636 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
NFKB1 P19838 1/20 0.46
APEX1 P27695 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4533042 0.93 ERBB2 (0.55) ERBB2EGFRERBB4JAK3MEN1
SCHEMBL6768225 0.91 ERBB2 (0.48) ERBB2EGFRERBB4JAK3MEN1
SCHEMBL6767483 0.89 ERBB2 (0.48) ERBB2EGFRERBB4JAK3MEN1
SCHEMBL6768728 0.84 ERBB2 (0.54) ERBB2EGFRERBB4JAK3MEN1
SCHEMBL7517989 0.83 ERBB2 (0.66) ERBB2EGFRERBB4JAK3MEN1
SCHEMBL4534051 0.83 ERBB2 (0.54) ERBB2EGFRERBB4JAK3MEN1
SCHEMBL6768670 0.81 ERBB2 (0.54) ERBB2EGFRERBB4JAK3MEN1
SCHEMBL6766568 0.81 ERBB2 (0.63) ERBB2EGFRERBB4JAK3MEN1
SCHEMBL6764001 0.79 ERBB2 (0.65) ERBB2EGFRERBB4JAK3MEN1
SCHEMBL6889749 0.78 ERBB2 (0.65) ERBB2EGFRERBB4JAK3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6828320-B2 Enzyme inhibitors; anticancer agents SMITHKLINE BEECHAM CORPORATION 2004-12-07 US disclosed
US-6391874-B1 ANTICARCINOGENIC AGENTS; SKIN DISORDERS SMITHKLINE BEECHAM CORPORATION 2002-05-21 US disclosed